サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1125827

世界のクリプトコッカス症治療薬市場：考察と予測 (2028年まで)

Global Cryptococcosis Therapeutics Market Insights, Forecast to 2028
出版日: | 発行: QYResearch | ページ情報: 英文 115 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
世界のクリプトコッカス症治療薬市場：考察と予測 (2028年まで)
出版日: 2022年09月16日
発行: QYResearch
ページ情報: 英文 115 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、クリプトコッカス症治療薬 (Cryptococcosis Therapeutics) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場分析：タイプ別
    • 世界のクリプトコッカス症治療薬の市場規模成長率：タイプ別, 2017 VS 2021 VS 2028
    • Amphotericin B
    • Flucytosine
    • Fluconazole
    • Others
  • 市場：アプリケーション別
    • 世界のクリプトコッカス症治療薬の市場規模成長率：アプリケーション別, 2017 VS 2021 VS 2028
    • Hospital Pharmacy
    • Retail Pharmacy
    • Others
  • 調査目的
  • 対象期間

第2章 世界の市場成長トレンド

  • 世界のクリプトコッカス症治療薬の市場展望 (2017-2028)
  • クリプトコッカス症治療薬の市場成長トレンド：地域別
    • クリプトコッカス症治療薬 市場規模：地域別: 2017 VS 2021 VS 2028
    • クリプトコッカス症治療薬の市場規模実績：地域別 (2017-2022)
    • クリプトコッカス症治療薬の市場規模予測：地域別 (2023-2028)
  • クリプトコッカス症治療薬 市場動向
    • クリプトコッカス症治療薬 業界動向
    • クリプトコッカス症治療薬 市場の促進要因
    • クリプトコッカス症治療薬 市場の課題
    • クリプトコッカス症治療薬 市場の抑制要因

第3章 競合情勢：主要企業別

  • 世界のクリプトコッカス症治療薬の上位企業：収益別
    • 世界のクリプトコッカス症治療薬の上位企業：収益別 (2017-2022)
    • 世界のクリプトコッカス症治療薬の収益シェア：企業別 (2017-2022)
  • 世界のクリプトコッカス症治療薬の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 企業ランキング：クリプトコッカス症治療薬の収益
  • 世界のクリプトコッカス症治療薬 市場集中度
    • 世界のクリプトコッカス症治療薬 市場集中度 (CR5 and HHI)
    • 世界の上位10・上位5企業： クリプトコッカス症治療薬の収益 2021
  • クリプトコッカス症治療薬の主要企業の本社および事業エリア
  • 主要企業 クリプトコッカス症治療薬の製品ソリューションおよびサービス
  • 市場参入時期： クリプトコッカス症治療薬 市場
  • M&A, 拡張計画

第4章 クリプトコッカス症治療薬 内訳データ：タイプ別

  • 世界のクリプトコッカス症治療薬の市場規模実績：タイプ別 (2017-2022)
  • 世界のクリプトコッカス症治療薬の市場規模予測：タイプ別 (2023-2028)

第5章 クリプトコッカス症治療薬 内訳データ：アプリケーション別

  • 世界のクリプトコッカス症治療薬の市場規模実績：アプリケーション別 (2017-2022)
  • 世界のクリプトコッカス症治療薬の市場規模予測：アプリケーション別 (2023-2028)

第6章 北米

  • 北米のクリプトコッカス症治療薬 市場規模 (2017-2028)
  • 北米のクリプトコッカス症治療薬 市場規模：タイプ別
    • 北米のクリプトコッカス症治療薬 市場規模：タイプ別 (2017-2022)
    • 北米のクリプトコッカス症治療薬 市場規模：タイプ別 (2023-2028)
    • 北米のクリプトコッカス症治療薬の市場シェア：タイプ別 (2017-2028)
  • 北米のクリプトコッカス症治療薬 市場規模：アプリケーション別
    • 北米のクリプトコッカス症治療薬 市場規模：アプリケーション別 (2017-2022)
    • 北米のクリプトコッカス症治療薬 市場規模：アプリケーション別 (2023-2028)
    • 北米のクリプトコッカス症治療薬の市場シェア：アプリケーション別 (2017-2028)
  • 北米のクリプトコッカス症治療薬 市場規模：国別
    • 北米のクリプトコッカス症治療薬 市場規模：国別 (2017-2022)
    • 北米のクリプトコッカス症治療薬 市場規模：国別 (2023-2028)
    • 米国
    • カナダ

第7章 欧州

  • 欧州のクリプトコッカス症治療薬 市場規模 (2017-2028)
  • 欧州のクリプトコッカス症治療薬 市場規模：タイプ別
    • 欧州のクリプトコッカス症治療薬 市場規模：タイプ別 (2017-2022)
    • 欧州のクリプトコッカス症治療薬 市場規模：タイプ別 (2023-2028)
    • 欧州のクリプトコッカス症治療薬の市場シェア：タイプ別 (2017-2028)
  • 欧州のクリプトコッカス症治療薬 市場規模：アプリケーション別
    • 欧州のクリプトコッカス症治療薬 市場規模：アプリケーション別 (2017-2022)
    • 欧州のクリプトコッカス症治療薬 市場規模：アプリケーション別 (2023-2028)
    • 欧州のクリプトコッカス症治療薬の市場シェア：アプリケーション別 (2017-2028)
  • 欧州のクリプトコッカス症治療薬 市場規模：国別
    • 欧州のクリプトコッカス症治療薬 市場規模：国別 (2017-2022)
    • 欧州のクリプトコッカス症治療薬 市場規模：国別 (2023-2028)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
    • 北欧

第8章 アジア太平洋地域

  • アジア太平洋地域 クリプトコッカス症治療薬 市場規模 (2017-2028)
  • アジア太平洋地域 クリプトコッカス症治療薬 市場規模：タイプ別
    • アジア太平洋地域 クリプトコッカス症治療薬 市場規模：タイプ別 (2017-2022)
    • アジア太平洋地域 クリプトコッカス症治療薬 市場規模：タイプ別 (2023-2028)
    • アジア太平洋地域 クリプトコッカス症治療薬の市場シェア：タイプ別 (2017-2028)
  • アジア太平洋地域 クリプトコッカス症治療薬 市場規模：アプリケーション別
    • アジア太平洋地域 クリプトコッカス症治療薬 市場規模：アプリケーション別 (2017-2022)
    • アジア太平洋地域 クリプトコッカス症治療薬 市場規模：アプリケーション別 (2023-2028)
    • アジア太平洋地域 クリプトコッカス症治療薬の市場シェア：アプリケーション別 (2017-2028)
  • アジア太平洋地域 クリプトコッカス症治療薬 市場規模：地域別
    • アジア太平洋地域 クリプトコッカス症治療薬 市場規模：地域別 (2017-2022)
    • アジア太平洋地域 クリプトコッカス症治療薬 市場規模：地域別 (2023-2028)
    • 中国
    • 日本
    • 韓国
    • 東南アジア
    • インド
    • オーストラリア

第9章 ラテンアメリカ

  • ラテンアメリカのクリプトコッカス症治療薬 市場規模 (2017-2028)
  • ラテンアメリカのクリプトコッカス症治療薬 市場規模：タイプ別
    • ラテンアメリカのクリプトコッカス症治療薬 市場規模：タイプ別 (2017-2022)
    • ラテンアメリカのクリプトコッカス症治療薬 市場規模：タイプ別 (2023-2028)
    • ラテンアメリカのクリプトコッカス症治療薬の市場シェア：タイプ別 (2017-2028)
  • ラテンアメリカのクリプトコッカス症治療薬 市場規模：アプリケーション別
    • ラテンアメリカのクリプトコッカス症治療薬 市場規模：アプリケーション別 (2017-2022)
    • ラテンアメリカのクリプトコッカス症治療薬 市場規模：アプリケーション別 (2023-2028)
    • ラテンアメリカのクリプトコッカス症治療薬の市場シェア：アプリケーション別 (2017-2028)
  • ラテンアメリカのクリプトコッカス症治療薬 市場規模：国別
    • ラテンアメリカのクリプトコッカス症治療薬 市場規模：国別 (2017-2022)
    • ラテンアメリカのクリプトコッカス症治療薬 市場規模：国別 (2023-2028)
    • メキシコ
    • ブラジル

第10章 中東・アフリカ

  • 中東・アフリカのクリプトコッカス症治療薬 市場規模 (2017-2028)
  • 中東・アフリカのクリプトコッカス症治療薬 市場規模：タイプ別
    • 中東・アフリカのクリプトコッカス症治療薬 市場規模：タイプ別 (2017-2022)
    • 中東・アフリカのクリプトコッカス症治療薬 市場規模：タイプ別 (2023-2028)
    • 中東・アフリカのクリプトコッカス症治療薬の市場シェア：タイプ別 (2017-2028)
  • 中東・アフリカのクリプトコッカス症治療薬 市場規模：アプリケーション別
    • 中東・アフリカのクリプトコッカス症治療薬 市場規模：アプリケーション別 (2017-2022)
    • 中東・アフリカのクリプトコッカス症治療薬 市場規模：アプリケーション別 (2023-2028)
    • 中東・アフリカのクリプトコッカス症治療薬の市場シェア：アプリケーション別 (2017-2028)
  • 中東・アフリカのクリプトコッカス症治療薬 市場規模：国別
    • 中東・アフリカのクリプトコッカス症治療薬 市場規模：国別 (2017-2022)
    • 中東・アフリカのクリプトコッカス症治療薬 市場規模：国別 (2023-2028)
    • トルコ
    • サウジアラビア
    • UAE

第11章 主要企業のプロファイル

  • Bristol-Myers Squibb
  • Abbott Laboratories
  • Pfizer
  • Glenmark Pharmaceuticals
  • Bausch Health
  • Johnson & Johnson
  • Novartis AG
  • Janssen Biotech
  • Sigmapharm Laboratories
  • Astellas Pharma Inc
  • Valeant Pharmaceuticals

第12章 アナリストによる分析/結論

第13章 付録

図表
  • Table 1. Global Cryptococcosis Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
  • Table 2. Key Players of Amphotericin B
  • Table 3. Key Players of Flucytosine
  • Table 4. Key Players of Fluconazole
  • Table 5. Key Players of Others
  • Table 6. Global Cryptococcosis Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
  • Table 7. Global Cryptococcosis Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 8. Global Cryptococcosis Therapeutics Market Size by Region (2017-2022) & (US$ Million)
  • Table 9. Global Cryptococcosis Therapeutics Market Share by Region (2017-2022)
  • Table 10. Global Cryptococcosis Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 11. Global Cryptococcosis Therapeutics Market Share by Region (2023-2028)
  • Table 12. Cryptococcosis Therapeutics Market Trends
  • Table 13. Cryptococcosis Therapeutics Market Drivers
  • Table 14. Cryptococcosis Therapeutics Market Challenges
  • Table 15. Cryptococcosis Therapeutics Market Restraints
  • Table 16. Global Cryptococcosis Therapeutics Revenue by Players (2017-2022) & (US$ Million)
  • Table 17. Global Cryptococcosis Therapeutics Revenue Share by Players (2017-2022)
  • Table 18. Global Top Cryptococcosis Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cryptococcosis Therapeutics as of 2021)
  • Table 19. Ranking of Global Top Cryptococcosis Therapeutics Companies by Revenue (US$ Million) in 2021
  • Table 20. Global 5 Largest Players Market Share by Cryptococcosis Therapeutics Revenue (CR5 and HHI) & (2017-2022)
  • Table 21. Key Players Headquarters and Area Served
  • Table 22. Key Players Cryptococcosis Therapeutics Product Solution and Service
  • Table 23. Date of Enter into Cryptococcosis Therapeutics Market
  • Table 24. Mergers & Acquisitions, Expansion Plans
  • Table 25. Global Cryptococcosis Therapeutics Market Size by Type (2017-2022) & (US$ Million)
  • Table 26. Global Cryptococcosis Therapeutics Revenue Market Share by Type (2017-2022)
  • Table 27. Global Cryptococcosis Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 28. Global Cryptococcosis Therapeutics Revenue Market Share by Type (2023-2028)
  • Table 29. Global Cryptococcosis Therapeutics Market Size by Application (2017-2022) & (US$ Million)
  • Table 30. Global Cryptococcosis Therapeutics Revenue Share by Application (2017-2022)
  • Table 31. Global Cryptococcosis Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 32. Global Cryptococcosis Therapeutics Revenue Share by Application (2023-2028)
  • Table 33. North America Cryptococcosis Therapeutics Market Size by Type (2017-2022) & (US$ Million)
  • Table 34. North America Cryptococcosis Therapeutics Market Size by Type (2023-2028) & (US$ Million)
  • Table 35. North America Cryptococcosis Therapeutics Market Size by Application (2017-2022) & (US$ Million)
  • Table 36. North America Cryptococcosis Therapeutics Market Size by Application (2023-2028) & (US$ Million)
  • Table 37. North America Cryptococcosis Therapeutics Market Size by Country (2017-2022) & (US$ Million)
  • Table 38. North America Cryptococcosis Therapeutics Market Size by Country (2023-2028) & (US$ Million)
  • Table 39. Europe Cryptococcosis Therapeutics Market Size by Type (2017-2022) & (US$ Million)
  • Table 40. Europe Cryptococcosis Therapeutics Market Size by Type (2023-2028) & (US$ Million)
  • Table 41. Europe Cryptococcosis Therapeutics Market Size by Application (2017-2022) & (US$ Million)
  • Table 42. Europe Cryptococcosis Therapeutics Market Size by Application (2023-2028) & (US$ Million)
  • Table 43. Europe Cryptococcosis Therapeutics Market Size by Country (2017-2022) & (US$ Million)
  • Table 44. Europe Cryptococcosis Therapeutics Market Size by Country (2023-2028) & (US$ Million)
  • Table 45. Asia Pacific Cryptococcosis Therapeutics Market Size by Type (2017-2022) & (US$ Million)
  • Table 46. Asia Pacific Cryptococcosis Therapeutics Market Size by Type (2023-2028) & (US$ Million)
  • Table 47. Asia Pacific Cryptococcosis Therapeutics Market Size by Application (2017-2022) & (US$ Million)
  • Table 48. Asia Pacific Cryptococcosis Therapeutics Market Size by Application (2023-2028) & (US$ Million)
  • Table 49. Asia Pacific Cryptococcosis Therapeutics Market Size by Region (2017-2022) & (US$ Million)
  • Table 50. Asia Pacific Cryptococcosis Therapeutics Market Size by Region (2023-2028) & (US$ Million)
  • Table 51. Latin America Cryptococcosis Therapeutics Market Size by Type (2017-2022) & (US$ Million)
  • Table 52. Latin America Cryptococcosis Therapeutics Market Size by Type (2023-2028) & (US$ Million)
  • Table 53. Latin America Cryptococcosis Therapeutics Market Size by Application (2017-2022) & (US$ Million)
  • Table 54. Latin America Cryptococcosis Therapeutics Market Size by Application (2023-2028) & (US$ Million)
  • Table 55. Latin America Cryptococcosis Therapeutics Market Size by Country (2017-2022) & (US$ Million)
  • Table 56. Latin America Cryptococcosis Therapeutics Market Size by Country (2023-2028) & (US$ Million)
  • Table 57. Middle East and Africa Cryptococcosis Therapeutics Market Size by Type (2017-2022) & (US$ Million)
  • Table 58. Middle East and Africa Cryptococcosis Therapeutics Market Size by Type (2023-2028) & (US$ Million)
  • Table 59. Middle East and Africa Cryptococcosis Therapeutics Market Size by Application (2017-2022) & (US$ Million)
  • Table 60. Middle East and Africa Cryptococcosis Therapeutics Market Size by Application (2023-2028) & (US$ Million)
  • Table 61. Middle East and Africa Cryptococcosis Therapeutics Market Size by Country (2017-2022) & (US$ Million)
  • Table 62. Middle East and Africa Cryptococcosis Therapeutics Market Size by Country (2023-2028) & (US$ Million)
  • Table 63. Bristol-Myers Squibb Company Details
  • Table 64. Bristol-Myers Squibb Business Overview
  • Table 65. Bristol-Myers Squibb Cryptococcosis Therapeutics Product
  • Table 66. Bristol-Myers Squibb Revenue in Cryptococcosis Therapeutics Business (2017-2022) & (US$ Million)
  • Table 67. Bristol-Myers Squibb Recent Developments
  • Table 68. Abbott Laboratories Company Details
  • Table 69. Abbott Laboratories Business Overview
  • Table 70. Abbott Laboratories Cryptococcosis Therapeutics Product
  • Table 71. Abbott Laboratories Revenue in Cryptococcosis Therapeutics Business (2017-2022) & (US$ Million)
  • Table 72. Abbott Laboratories Recent Developments
  • Table 73. Pfizer Company Details
  • Table 74. Pfizer Business Overview
  • Table 75. Pfizer Cryptococcosis Therapeutics Product
  • Table 76. Pfizer Revenue in Cryptococcosis Therapeutics Business (2017-2022) & (US$ Million)
  • Table 77. Pfizer Recent Developments
  • Table 78. Glenmark Pharmaceuticals Company Details
  • Table 79. Glenmark Pharmaceuticals Business Overview
  • Table 80. Glenmark Pharmaceuticals Cryptococcosis Therapeutics Product
  • Table 81. Glenmark Pharmaceuticals Revenue in Cryptococcosis Therapeutics Business (2017-2022) & (US$ Million)
  • Table 82. Glenmark Pharmaceuticals Recent Developments
  • Table 83. Bausch Health Company Details
  • Table 84. Bausch Health Business Overview
  • Table 85. Bausch Health Cryptococcosis Therapeutics Product
  • Table 86. Bausch Health Revenue in Cryptococcosis Therapeutics Business (2017-2022) & (US$ Million)
  • Table 87. Bausch Health Recent Developments
  • Table 88. Johnson & Johnson Company Details
  • Table 89. Johnson & Johnson Business Overview
  • Table 90. Johnson & Johnson Cryptococcosis Therapeutics Product
  • Table 91. Johnson & Johnson Revenue in Cryptococcosis Therapeutics Business (2017-2022) & (US$ Million)
  • Table 92. Johnson & Johnson Recent Developments
  • Table 93. Novartis AG Company Details
  • Table 94. Novartis AG Business Overview
  • Table 95. Novartis AG Cryptococcosis Therapeutics Product
  • Table 96. Novartis AG Revenue in Cryptococcosis Therapeutics Business (2017-2022) & (US$ Million)
  • Table 97. Novartis AG Recent Developments
  • Table 98. Janssen Biotech Company Details
  • Table 99. Janssen Biotech Business Overview
  • Table 100. Janssen Biotech Cryptococcosis Therapeutics Product
  • Table 101. Janssen Biotech Revenue in Cryptococcosis Therapeutics Business (2017-2022) & (US$ Million)
  • Table 102. Janssen Biotech Recent Developments
  • Table 103. Sigmapharm Laboratories Company Details
  • Table 104. Sigmapharm Laboratories Business Overview
  • Table 105. Sigmapharm Laboratories Cryptococcosis Therapeutics Product
  • Table 106. Sigmapharm Laboratories Revenue in Cryptococcosis Therapeutics Business (2017-2022) & (US$ Million)
  • Table 107. Sigmapharm Laboratories Recent Developments
  • Table 108. Astellas Pharma Inc Company Details
  • Table 109. Astellas Pharma Inc Business Overview
  • Table 110. Astellas Pharma Inc Cryptococcosis Therapeutics Product
  • Table 111. Astellas Pharma Inc Revenue in Cryptococcosis Therapeutics Business (2017-2022) & (US$ Million)
  • Table 112. Astellas Pharma Inc Recent Developments
  • Table 113. Valeant Pharmaceuticals Company Details
  • Table 114. Valeant Pharmaceuticals Business Overview
  • Table 115. Valeant Pharmaceuticals Cryptococcosis Therapeutics Product
  • Table 116. Valeant Pharmaceuticals Revenue in Cryptococcosis Therapeutics Business (2017-2022) & (US$ Million)
  • Table 117. Valeant Pharmaceuticals Recent Developments
  • Table 118. Research Programs/Design for This Report
  • Table 119. Key Data Information from Secondary Sources
  • Table 120. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Cryptococcosis Therapeutics Market Share by Type: 2021 VS 2028
  • Figure 2. Amphotericin B Features
  • Figure 3. Flucytosine Features
  • Figure 4. Fluconazole Features
  • Figure 5. Others Features
  • Figure 6. Global Cryptococcosis Therapeutics Market Share by Application: 2021 VS 2028
  • Figure 7. Hospital Pharmacy Case Studies
  • Figure 8. Retail Pharmacy Case Studies
  • Figure 9. Others Case Studies
  • Figure 10. Cryptococcosis Therapeutics Report Years Considered
  • Figure 11. Global Cryptococcosis Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 12. Global Cryptococcosis Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 13. Global Cryptococcosis Therapeutics Market Share by Region: 2021 VS 2028
  • Figure 14. Global Cryptococcosis Therapeutics Market Share by Players in 2021
  • Figure 15. Global Top Cryptococcosis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cryptococcosis Therapeutics as of 2021)
  • Figure 16. The Top 10 and 5 Players Market Share by Cryptococcosis Therapeutics Revenue in 2021
  • Figure 17. North America Cryptococcosis Therapeutics Market Size YoY (2017-2028) & (US$ Million)
  • Figure 18. North America Cryptococcosis Therapeutics Market Size Market Share by Type (2017-2028)
  • Figure 19. North America Cryptococcosis Therapeutics Market Size Market Share by Application (2017-2028)
  • Figure 20. North America Cryptococcosis Therapeutics Market Size Share by Country (2017-2028)
  • Figure 21. United States Cryptococcosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 22. Canada Cryptococcosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 23. Europe Cryptococcosis Therapeutics Market Size YoY (2017-2028) & (US$ Million)
  • Figure 24. Europe Cryptococcosis Therapeutics Market Size Market Share by Type (2017-2028)
  • Figure 25. Europe Cryptococcosis Therapeutics Market Size Market Share by Application (2017-2028)
  • Figure 26. Europe Cryptococcosis Therapeutics Market Size Share by Country (2017-2028)
  • Figure 27. Germany Cryptococcosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 28. France Cryptococcosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 29. U.K. Cryptococcosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 30. Italy Cryptococcosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 31. Russia Cryptococcosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 32. Nordic Countries Cryptococcosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 33. Asia-Pacific Cryptococcosis Therapeutics Market Size YoY (2017-2028) & (US$ Million)
  • Figure 34. Asia Pacific Cryptococcosis Therapeutics Market Size Market Share by Type (2017-2028)
  • Figure 35. Asia Pacific Cryptococcosis Therapeutics Market Size Market Share by Application (2017-2028)
  • Figure 36. Asia Pacific Cryptococcosis Therapeutics Market Size Share by Region (2017-2028)
  • Figure 37. China Cryptococcosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 38. Japan Cryptococcosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 39. South Korea Cryptococcosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 40. Southeast Asia Cryptococcosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 41. India Cryptococcosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 42. Australia Cryptococcosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 43. Latin America Cryptococcosis Therapeutics Market Size YoY (2017-2028) & (US$ Million)
  • Figure 44. Latin America Cryptococcosis Therapeutics Market Size Market Share by Type (2017-2028)
  • Figure 45. Latin America Cryptococcosis Therapeutics Market Size Market Share by Application (2017-2028)
  • Figure 46. Latin America Cryptococcosis Therapeutics Market Size Share by Country (2017-2028)
  • Figure 47. Mexico Cryptococcosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 48. Brazil Cryptococcosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 49. Middle East & Africa Cryptococcosis Therapeutics Market Size YoY (2017-2028) & (US$ Million)
  • Figure 50. Middle East and Africa Cryptococcosis Therapeutics Market Size Market Share by Type (2017-2028)
  • Figure 51. Middle East and Africa Cryptococcosis Therapeutics Market Size Market Share by Application (2017-2028)
  • Figure 52. Middle East and Africa Cryptococcosis Therapeutics Market Size Share by Country (2017-2028)
  • Figure 53. Turkey Cryptococcosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 54. Saudi Arabia Cryptococcosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 55. UAE Cryptococcosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 56. Bristol-Myers Squibb Revenue Growth Rate in Cryptococcosis Therapeutics Business (2017-2022)
  • Figure 57. Abbott Laboratories Revenue Growth Rate in Cryptococcosis Therapeutics Business (2017-2022)
  • Figure 58. Pfizer Revenue Growth Rate in Cryptococcosis Therapeutics Business (2017-2022)
  • Figure 59. Glenmark Pharmaceuticals Revenue Growth Rate in Cryptococcosis Therapeutics Business (2017-2022)
  • Figure 60. Bausch Health Revenue Growth Rate in Cryptococcosis Therapeutics Business (2017-2022)
  • Figure 61. Johnson & Johnson Revenue Growth Rate in Cryptococcosis Therapeutics Business (2017-2022)
  • Figure 62. Novartis AG Revenue Growth Rate in Cryptococcosis Therapeutics Business (2017-2022)
  • Figure 63. Janssen Biotech Revenue Growth Rate in Cryptococcosis Therapeutics Business (2017-2022)
  • Figure 64. Sigmapharm Laboratories Revenue Growth Rate in Cryptococcosis Therapeutics Business (2017-2022)
  • Figure 65. Astellas Pharma Inc Revenue Growth Rate in Cryptococcosis Therapeutics Business (2017-2022)
  • Figure 66. Valeant Pharmaceuticals Revenue Growth Rate in Cryptococcosis Therapeutics Business (2017-2022)
  • Figure 67. Bottom-up and Top-down Approaches for This Report
  • Figure 68. Data Triangulation
  • Figure 69. Key Executives Interviewed
目次

This research report focuses on the Cryptococcosis Therapeutics Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Cryptococcosis Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Amphotericin B
    • 1.2.3 Flucytosine
    • 1.2.4 Fluconazole
    • 1.2.5 Others
  • 1.3 Market by Application
    • 1.3.1 Global Cryptococcosis Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Hospital Pharmacy
    • 1.3.3 Retail Pharmacy
    • 1.3.4 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Cryptococcosis Therapeutics Market Perspective (2017-2028)
  • 2.2 Cryptococcosis Therapeutics Growth Trends by Region
    • 2.2.1 Cryptococcosis Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 Cryptococcosis Therapeutics Historic Market Size by Region (2017-2022)
    • 2.2.3 Cryptococcosis Therapeutics Forecasted Market Size by Region (2023-2028)
  • 2.3 Cryptococcosis Therapeutics Market Dynamics
    • 2.3.1 Cryptococcosis Therapeutics Industry Trends
    • 2.3.2 Cryptococcosis Therapeutics Market Drivers
    • 2.3.3 Cryptococcosis Therapeutics Market Challenges
    • 2.3.4 Cryptococcosis Therapeutics Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Cryptococcosis Therapeutics Players by Revenue
    • 3.1.1 Global Top Cryptococcosis Therapeutics Players by Revenue (2017-2022)
    • 3.1.2 Global Cryptococcosis Therapeutics Revenue Market Share by Players (2017-2022)
  • 3.2 Global Cryptococcosis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Cryptococcosis Therapeutics Revenue
  • 3.4 Global Cryptococcosis Therapeutics Market Concentration Ratio
    • 3.4.1 Global Cryptococcosis Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Cryptococcosis Therapeutics Revenue in 2021
  • 3.5 Cryptococcosis Therapeutics Key Players Head office and Area Served
  • 3.6 Key Players Cryptococcosis Therapeutics Product Solution and Service
  • 3.7 Date of Enter into Cryptococcosis Therapeutics Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Cryptococcosis Therapeutics Breakdown Data by Type

  • 4.1 Global Cryptococcosis Therapeutics Historic Market Size by Type (2017-2022)
  • 4.2 Global Cryptococcosis Therapeutics Forecasted Market Size by Type (2023-2028)

5 Cryptococcosis Therapeutics Breakdown Data by Application

  • 5.1 Global Cryptococcosis Therapeutics Historic Market Size by Application (2017-2022)
  • 5.2 Global Cryptococcosis Therapeutics Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America Cryptococcosis Therapeutics Market Size (2017-2028)
  • 6.2 North America Cryptococcosis Therapeutics Market Size by Type
    • 6.2.1 North America Cryptococcosis Therapeutics Market Size by Type (2017-2022)
    • 6.2.2 North America Cryptococcosis Therapeutics Market Size by Type (2023-2028)
    • 6.2.3 North America Cryptococcosis Therapeutics Market Share by Type (2017-2028)
  • 6.3 North America Cryptococcosis Therapeutics Market Size by Application
    • 6.3.1 North America Cryptococcosis Therapeutics Market Size by Application (2017-2022)
    • 6.3.2 North America Cryptococcosis Therapeutics Market Size by Application (2023-2028)
    • 6.3.3 North America Cryptococcosis Therapeutics Market Share by Application (2017-2028)
  • 6.4 North America Cryptococcosis Therapeutics Market Size by Country
    • 6.4.1 North America Cryptococcosis Therapeutics Market Size by Country (2017-2022)
    • 6.4.2 North America Cryptococcosis Therapeutics Market Size by Country (2023-2028)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Cryptococcosis Therapeutics Market Size (2017-2028)
  • 7.2 Europe Cryptococcosis Therapeutics Market Size by Type
    • 7.2.1 Europe Cryptococcosis Therapeutics Market Size by Type (2017-2022)
    • 7.2.2 Europe Cryptococcosis Therapeutics Market Size by Type (2023-2028)
    • 7.2.3 Europe Cryptococcosis Therapeutics Market Share by Type (2017-2028)
  • 7.3 Europe Cryptococcosis Therapeutics Market Size by Application
    • 7.3.1 Europe Cryptococcosis Therapeutics Market Size by Application (2017-2022)
    • 7.3.2 Europe Cryptococcosis Therapeutics Market Size by Application (2023-2028)
    • 7.3.3 Europe Cryptococcosis Therapeutics Market Share by Application (2017-2028)
  • 7.4 Europe Cryptococcosis Therapeutics Market Size by Country
    • 7.4.1 Europe Cryptococcosis Therapeutics Market Size by Country (2017-2022)
    • 7.4.2 Europe Cryptococcosis Therapeutics Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific Cryptococcosis Therapeutics Market Size (2017-2028)
  • 8.2 Asia-Pacific Cryptococcosis Therapeutics Market Size by Type
    • 8.2.1 Asia-Pacific Cryptococcosis Therapeutics Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific Cryptococcosis Therapeutics Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific Cryptococcosis Therapeutics Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific Cryptococcosis Therapeutics Market Size by Application
    • 8.3.1 Asia-Pacific Cryptococcosis Therapeutics Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific Cryptococcosis Therapeutics Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific Cryptococcosis Therapeutics Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific Cryptococcosis Therapeutics Market Size by Region
    • 8.4.1 Asia-Pacific Cryptococcosis Therapeutics Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific Cryptococcosis Therapeutics Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Cryptococcosis Therapeutics Market Size (2017-2028)
  • 9.2 Latin America Cryptococcosis Therapeutics Market Size by Type
    • 9.2.1 Latin America Cryptococcosis Therapeutics Market Size by Type (2017-2022)
    • 9.2.2 Latin America Cryptococcosis Therapeutics Market Size by Type (2023-2028)
    • 9.2.3 Latin America Cryptococcosis Therapeutics Market Share by Type (2017-2028)
  • 9.3 Latin America Cryptococcosis Therapeutics Market Size by Application
    • 9.3.1 Latin America Cryptococcosis Therapeutics Market Size by Application (2017-2022)
    • 9.3.2 Latin America Cryptococcosis Therapeutics Market Size by Application (2023-2028)
    • 9.3.3 Latin America Cryptococcosis Therapeutics Market Share by Application (2017-2028)
  • 9.4 Latin America Cryptococcosis Therapeutics Market Size by Country
    • 9.4.1 Latin America Cryptococcosis Therapeutics Market Size by Country (2017-2022)
    • 9.4.2 Latin America Cryptococcosis Therapeutics Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Cryptococcosis Therapeutics Market Size (2017-2028)
  • 10.2 Middle East & Africa Cryptococcosis Therapeutics Market Size by Type
    • 10.2.1 Middle East & Africa Cryptococcosis Therapeutics Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa Cryptococcosis Therapeutics Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa Cryptococcosis Therapeutics Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa Cryptococcosis Therapeutics Market Size by Application
    • 10.3.1 Middle East & Africa Cryptococcosis Therapeutics Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa Cryptococcosis Therapeutics Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa Cryptococcosis Therapeutics Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa Cryptococcosis Therapeutics Market Size by Country
    • 10.4.1 Middle East & Africa Cryptococcosis Therapeutics Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa Cryptococcosis Therapeutics Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Bristol-Myers Squibb
    • 11.1.1 Bristol-Myers Squibb Company Details
    • 11.1.2 Bristol-Myers Squibb Business Overview
    • 11.1.3 Bristol-Myers Squibb Cryptococcosis Therapeutics Introduction
    • 11.1.4 Bristol-Myers Squibb Revenue in Cryptococcosis Therapeutics Business (2017-2022)
    • 11.1.5 Bristol-Myers Squibb Recent Developments
  • 11.2 Abbott Laboratories
    • 11.2.1 Abbott Laboratories Company Details
    • 11.2.2 Abbott Laboratories Business Overview
    • 11.2.3 Abbott Laboratories Cryptococcosis Therapeutics Introduction
    • 11.2.4 Abbott Laboratories Revenue in Cryptococcosis Therapeutics Business (2017-2022)
    • 11.2.5 Abbott Laboratories Recent Developments
  • 11.3 Pfizer
    • 11.3.1 Pfizer Company Details
    • 11.3.2 Pfizer Business Overview
    • 11.3.3 Pfizer Cryptococcosis Therapeutics Introduction
    • 11.3.4 Pfizer Revenue in Cryptococcosis Therapeutics Business (2017-2022)
    • 11.3.5 Pfizer Recent Developments
  • 11.4 Glenmark Pharmaceuticals
    • 11.4.1 Glenmark Pharmaceuticals Company Details
    • 11.4.2 Glenmark Pharmaceuticals Business Overview
    • 11.4.3 Glenmark Pharmaceuticals Cryptococcosis Therapeutics Introduction
    • 11.4.4 Glenmark Pharmaceuticals Revenue in Cryptococcosis Therapeutics Business (2017-2022)
    • 11.4.5 Glenmark Pharmaceuticals Recent Developments
  • 11.5 Bausch Health
    • 11.5.1 Bausch Health Company Details
    • 11.5.2 Bausch Health Business Overview
    • 11.5.3 Bausch Health Cryptococcosis Therapeutics Introduction
    • 11.5.4 Bausch Health Revenue in Cryptococcosis Therapeutics Business (2017-2022)
    • 11.5.5 Bausch Health Recent Developments
  • 11.6 Johnson & Johnson
    • 11.6.1 Johnson & Johnson Company Details
    • 11.6.2 Johnson & Johnson Business Overview
    • 11.6.3 Johnson & Johnson Cryptococcosis Therapeutics Introduction
    • 11.6.4 Johnson & Johnson Revenue in Cryptococcosis Therapeutics Business (2017-2022)
    • 11.6.5 Johnson & Johnson Recent Developments
  • 11.7 Novartis AG
    • 11.7.1 Novartis AG Company Details
    • 11.7.2 Novartis AG Business Overview
    • 11.7.3 Novartis AG Cryptococcosis Therapeutics Introduction
    • 11.7.4 Novartis AG Revenue in Cryptococcosis Therapeutics Business (2017-2022)
    • 11.7.5 Novartis AG Recent Developments
  • 11.8 Janssen Biotech
    • 11.8.1 Janssen Biotech Company Details
    • 11.8.2 Janssen Biotech Business Overview
    • 11.8.3 Janssen Biotech Cryptococcosis Therapeutics Introduction
    • 11.8.4 Janssen Biotech Revenue in Cryptococcosis Therapeutics Business (2017-2022)
    • 11.8.5 Janssen Biotech Recent Developments
  • 11.9 Sigmapharm Laboratories
    • 11.9.1 Sigmapharm Laboratories Company Details
    • 11.9.2 Sigmapharm Laboratories Business Overview
    • 11.9.3 Sigmapharm Laboratories Cryptococcosis Therapeutics Introduction
    • 11.9.4 Sigmapharm Laboratories Revenue in Cryptococcosis Therapeutics Business (2017-2022)
    • 11.9.5 Sigmapharm Laboratories Recent Developments
  • 11.10 Astellas Pharma Inc
    • 11.10.1 Astellas Pharma Inc Company Details
    • 11.10.2 Astellas Pharma Inc Business Overview
    • 11.10.3 Astellas Pharma Inc Cryptococcosis Therapeutics Introduction
    • 11.10.4 Astellas Pharma Inc Revenue in Cryptococcosis Therapeutics Business (2017-2022)
    • 11.10.5 Astellas Pharma Inc Recent Developments
  • 11.11 Valeant Pharmaceuticals
    • 11.11.1 Valeant Pharmaceuticals Company Details
    • 11.11.2 Valeant Pharmaceuticals Business Overview
    • 11.11.3 Valeant Pharmaceuticals Cryptococcosis Therapeutics Introduction
    • 11.11.4 Valeant Pharmaceuticals Revenue in Cryptococcosis Therapeutics Business (2017-2022)
    • 11.11.5 Valeant Pharmaceuticals Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer